Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Severe COVID-19 patients account for most of the mortality of this disease. Early detection and effective treatment of severe patients remain major challenges. Here, we performed proteomic and metabolomic profiling of sera from 46 COVID-19 and 53 control individuals. We then trained a machine learning model using proteomic and metabolomic measurements from a training cohort of 18 non-severe and 13 severe patients. The model correctly classified severe patients with an accuracy of 93.5%, and was further validated using ten independent patients, seven of which were correctly classified. We identified molecular changes in the sera of COVID-19 patients implicating dysregulation of macrophage, platelet degranulation and complement system pathways, and massive metabolic suppression. This study shows that it is possible to predict progression to severe COVID-19 disease using serum protein and metabolite biomarkers. Our data also uncovered molecular pathophysiology of COVID-19 with potential for developing anti-viral therapies.

[1]  Bang Wong,et al.  GeNets: a unified web platform for network-based genomic analyses , 2018, Nature Methods.

[2]  Dr Irin Hossain, MPH,et al.  The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) In Bangladesh: A Descriptive Study , 2020, Journal of Medical Science And clinical Research.

[3]  Bang Wong,et al.  GeNets: A unified web platform for network-based analyses of genomic data , 2018, Nature Methods.

[4]  Andrew Rowland,et al.  The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. , 2013, The international journal of biochemistry & cell biology.

[5]  T. L. Deem,et al.  Unconjugated Bilirubin Inhibits VCAM-1-Mediated Transendothelial Leukocyte Migration1 , 2005, The Journal of Immunology.

[6]  Devin K. Schweppe,et al.  TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples , 2020, Nature Methods.

[7]  R. Blakely,et al.  A dialogue between the immune system and brain, spoken in the language of serotonin. , 2013, ACS chemical neuroscience.

[8]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[9]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[10]  F. Liu,et al.  Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication , 2011, Lipids in Health and Disease.

[11]  G. Randall,et al.  Lipids in Innate Antiviral Defense , 2013, Cell Host & Microbe.

[12]  J. Chan,et al.  Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication , 2019, Viruses.

[13]  Kexin Liu,et al.  Correction to "Accelerated Lysis and Proteolytic Digestion of Biopsy-Level Fresh-Frozen and FFPE Tissue Samples Using Pressure Cycling Technology". , 2020, Journal of proteome research.

[14]  S. Opal,et al.  Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection , 2020, mBio.

[15]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[16]  J. Sung,et al.  Serum Amyloid A Is Not Useful in the Diagnosis of Severe Acute Respiratory Syndrome , 2006, Clinical chemistry.

[17]  John D Lambris,et al.  Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.

[18]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[19]  K. Ikuta,et al.  Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle , 2006, Microbes and Infection.

[20]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[21]  Novel Coronavirus Pneumonia Emergency Response Epidemiol Team.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[22]  Ruedi Aebersold,et al.  Mass-spectrometric exploration of proteome structure and function , 2016, Nature.

[23]  K. Chirco,et al.  C-Reactive Protein As a Mediator of Complement Activation and Inflammatory Signaling in Age-Related Macular Degeneration , 2018, Front. Immunol..

[24]  A. Fauci,et al.  Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor , 2012, Proceedings of the National Academy of Sciences.

[25]  B. Vernon‐roberts.  The effects of steroid hormones on macrophage activity. , 1969, International review of cytology.

[26]  E. Kirkness,et al.  Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging , 2020, Proceedings of the National Academy of Sciences.

[27]  N. Heaton,et al.  Multifaceted roles for lipids in viral infection , 2011, Trends in Microbiology.

[28]  Srinivas Murthy,et al.  Care for Critically Ill Patients With COVID-19. , 2020, JAMA.

[29]  Steven Y. C. Tong,et al.  Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 , 2020, Nature Medicine.

[30]  L. Marlow,et al.  Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. , 2002, Journal of molecular neuroscience : MN.

[31]  Yan Li,et al.  Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  A. Assinger.  Platelets and Infection – An Emerging Role of Platelets in Viral Infection , 2014, Front. Immunol..

[33]  J. Baillie,et al.  Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury , 2020, The Lancet.

[34]  Z. Zou,et al.  Prognostic Factors for Severe Acute Respiratory Syndrome: A Clinical Analysis of 165 Cases , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  N. Van Rooijen,et al.  Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis , 2011, The American Journal of Pathology.

[36]  Yan Li,et al.  The role of C5a in acute lung injury induced by highly pathogenic viral infections , 2015, Emerging Microbes & Infections.

[37]  Y. Li,et al.  Fatty Acid Metabolism is Associated With Disease Severity After H7N9 Infection , 2018, EBioMedicine.

[38]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[39]  L. Marnett,et al.  Lipid profiling reveals glycerophospholipid remodeling in zymosan-stimulated macrophages. , 2007, Biochemistry.

[40]  Mario Plebani,et al.  Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis , 2020, Clinica Chimica Acta.

[41]  B. Brüne,et al.  Regulation of macrophage function by sphingosine-1-phosphate. , 2009, Immunobiology.

[42]  Ryan R Brinkman,et al.  Dynamic molecular changes during the first week of human life follow a robust developmental trajectory , 2019, Nature Communications.

[43]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[44]  Lei Liu,et al.  The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing , 2020, medRxiv.

[45]  S. Barnum.  Complement: A primer for the coming therapeutic revolution. , 2017, Pharmacology & therapeutics.

[46]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[47]  H. Kirking,et al.  First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA , 2020, The Lancet.

[48]  B. Jiang,et al.  Comorbidities and multi-organ injuries in the treatment of COVID-19 , 2020, The Lancet.

[49]  W. Liu,et al.  Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome , 2018, Science Translational Medicine.

[50]  E. Passegué,et al.  The lung is a site of platelet biogenesis and a reservoir for hematopoietic progenitors , 2017, Nature.

[51]  R. Terkeltaub,et al.  Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production. , 2019, Cell metabolism.

[52]  J. Sung,et al.  Proteomic analysis reveals platelet factor 4 and beta‐thromboglobulin as prognostic markers in severe acute respiratory syndrome , 2012, Electrophoresis.

[53]  B. Ryffel,et al.  Complement C5 Activation during Influenza A Infection in Mice Contributes to Neutrophil Recruitment and Lung Injury , 2013, PloS one.

[54]  H. Chi,et al.  The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study , 2020, Clinical chemistry and laboratory medicine.

[55]  Zhan Zhang,et al.  Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study , 2020, medRxiv.

[56]  Rajaa Al-Raddadi,et al.  Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome , 2017, American journal of respiratory and critical care medicine.

[57]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[58]  M. Snyder,et al.  Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation , 2018, Nature Immunology.

[59]  C. Garlanda,et al.  Platelet-macrophage partnership in innate immunity and inflammation , 2013, Nature Immunology.

[60]  Lisa E. Gralinski,et al.  Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis , 2018, mBio.

[61]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[62]  Arul Earnest,et al.  Use of Simple Laboratory Features to Distinguish the Early Stage of Severe Acute Respiratory Syndrome from Dengue Fever , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  Shibo Jiang,et al.  Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV , 2018, Emerging Microbes & Infections.